Oncolytic Reovirus Inhibits Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in a TLR3-Dependent Manner

• Published in: The Journal of immunology (1950) Vol. 200; no. 8; pp. 2987 - 2999
• Main Authors: Katayama, Yuki, Tachibana, Masashi, Kurisu, Nozomi, Oya, Yukako, Terasawa, Yuichi, Goda, Hiroshi, Kobiyama, Kouji, Ishii, Ken J, Akira, Shizuo, Mizuguchi, Hiroyuki, Sakurai, Fuminori
• Format: Journal Article
• Language: English
• Published: United States American Association of Immunologists 15.04.2018
• Subjects: Animals; Antitumor activity; CD4 antigen; CD8 antigen; Cell activation; Cell proliferation; Double-stranded RNA; Genomes; Immunosuppression; Immunosuppressive agents; Lymphocytes; Lymphocytes T; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid-Derived Suppressor Cells - immunology; Neoplasms, Experimental - immunology; Oncolysis; Oncolytic Viruses - immunology; Reoviridae Infections - immunology; Rodents; Spleen; Stimulators; Suppressor cells; TLR3 protein; Toll-Like Receptor 3 - immunology; Toll-like receptors; Tumor Escape - immunology; Viruses; β-Interferon
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.1700435

Oncolytic reovirus, which possesses 10 segments of dsRNA genome, mediates antitumor effects via not only virus replication in a tumor cell-specific manner, but also activation of antitumor immunity; however, the mechanism(s) of reovirus-induced activation of antitumor immunity have not been fully elucidated. Recent studies have demonstrated that overcoming an immunosuppressive environment in tumor-bearing hosts is important to achieve efficient activation of antitumor immunity. Among the various types of cells involved in immunosuppression, it has been revealed that myeloid-derived suppressor cells (MDSCs) are significantly increased in tumor-bearing hosts and play crucial roles in the immunosuppression in tumor-bearing hosts. In this study, we examined whether reovirus inhibits the immunosuppressive activity of MDSCs, resulting in efficient activation of immune cells after in vivo administration. The results showed that splenic MDSCs recovered from PBS-treated tumor-bearing mice significantly suppressed the Ag-specific proliferation of CD8 T cells. In contrast, the suppressive activity of MDSCs on T cell proliferation was significantly reduced after reovirus administration. Reovirus also inhibited the immunosuppressive activity of MDSCs in IFN-β promoter stimulator-1 knockout (KO) mice and in wild-type mice. In contrast, the immunosuppressive activity of MDSCs in TLR-3 KO mice was not significantly altered by reovirus treatment. The activation levels of CD4 and CD8 T cells were significantly lower in TLR3 KO mice than in wild-type mice after reovirus administration. These results indicate that reovirus inhibits the immunosuppressive activity of MDSCs in a TLR3, but not IFN-β promoter stimulator-1, signaling-dependent manner.